Sodium Chloride
| Evidence Level: N/A | Predicted Indications: 0 |
Table of Contents
- Sodium Chloride
Sodium Chloride: Known uses and market status in Australia
Summary
The TxGNN model has no candidate with a score of 0.99 or higher for Sodium Chloride, so there is currently no new predicted indication. The drug’s recorded uses are listed below.
Quick overview
| Item | Content |
|---|---|
| New predicted indications | None (no model candidate scored 0.99 or higher) |
| Known uses recorded for this drug | 1 |
| Evidence level | Not applicable |
| Australia Market Status | Listed on the PBS Schedule (2 of 2 items) – TGA (ARTG) registration status is not included in this data |
| Number of PBS Items | 2 (valid: 2) |
Known uses recorded for this drug
Approved (supported by a licence or label)
| Indication | Source |
|---|---|
| fatigue | licence in another country |
Related to an approved indication (same disease category)
| Indication | Approved category |
|---|---|
| none | none |
Relations recorded in the knowledge graph (no approval found)
| Indication |
|---|
| none |
Australia Market Information
| Licence | Product | Dosage form | Status |
|---|---|---|---|
| 4460R | Baxter Healthcare Pty Ltd | Irrigation solution 9 mg per mL (0.9%), | Valid |
| 456B | nan | nan | Valid |
Safety Considerations
- Drug Interactions (both Moderate severity):
- Tolvaptan
- Lithium carbonate
For other warnings and contraindications, please refer to the TGA-approved Product Information (PI) for safety information.
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.